## Abstract In a case‐control study using a clinically well‐defined group of 30 multiple system atrophy (MSA) patients and 110 control subjects, homozygosity for interleukin‐1A (IL‐1A) allele 2 (high secretor of proinflammatory cytokine) in the regulatory region (‐889) of the IL‐1A gene was associa
Contribution of the interleukin-1β gene polymorphism in multiple system atrophy
✍ Scribed by Masataka Nishimura; Hideshi Kawakami; Osamu Komure; Hirofumi Maruyama; Hiroyuki Morino; Yuishin Izumi; Shigenobu Nakamura; Ryuji Kaji; Sadako Kuno
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 60 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
We studied genetic polymorphisms in the promoter region at position -511 of the interleukin (IL) -1beta gene (IL-1B-511) and at position -889 of the IL-1alpha gene (IL-1A-889), in 111 Japanese patients with multiple system atrophy (MSA) and 160 controls. The distribution of IL-1B-511 was significantly different between MSA patients and controls, because of the under-representation of patients with homozygotes for allele 2 (IL-1B-511*2), a high producer of IL-1beta. The frequency of IL-1A-889*2, a high secretor of IL-1alpha, was also decreased in MSA patients. Our findings suggest that abnormal cytokine expression may be implicated in the pathogenesis of MSA.
📜 SIMILAR VOLUMES
## Abstract ## Objective Significant variation in interleukin‐1β (IL‐1β) protein secretion between subjects has been observed when using a lipopolysaccharide (LPS)/ATP–mediated ex vivo blood stimulation assay. To explore the potential relationships between genetic polymorphisms in the __IL1B__ cyt
## Abstract Multiple system atrophy (MSA) is an adult‐onset sporadic neurodegenerative disease. Although the etiology of MSA remains obscure, recent studies suggest that oxidative stress is associated with the pathogenesis of MSA. The aim of this study was to evaluate genetic associations between t
## Abstract Multiple system atrophy (MSA) is a neurodegenerative disease characterized by various degrees of Parkinsonism, cerebellar ataxia, and autonomic dysfunction. In this report, Affymetrix DNA microarrays were used to measure changes in gene expression in the rostral pons, an area that under